Old Web
English
Sign In
Acemap
>
authorDetail
>
Linda C. Stork
Linda C. Stork
Children's Oncology Group
Internal medicine
Medicine
Cancer
Oncology
Immunology
3
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Children's Oncology Group for standard-risk acute lymphoblastic leukemia, reported by the methotrexate: results of the Children's Cancer Group (CCG) 1952 study fails to improve event-free survival when compared with intrathecal Intrathecal triple therapy decreases central nervous system relapse but
2013
M. Wells
April D. Sorrell
Margaret Masterson
John F. Kelleher
Linda C. Stork
Rochelle Yanofsky
Raymond J. Hutchinson
Nyla A. Heerema
James Nachman
Marilyn Blake
Linda Yousif Matloub
Susan Lindemulder
Paul S. Gaynon
Harland N. Sather
Emmett Broxson
Show All
Source
Cite
Save
Citations (0)
Failure of Asparagine (ASN) Depletion, Not Inadequate Asparaginase (ASNase) Activity, Predicts Relapse in Standard Risk (SR) Childhood Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group (COG) Report.
2007
Blood
Vassilios I. Avramis
John S. Holcenberg
Alice G. Ettinger
Linda C. Stork
Mei La
Paul S. Gaynon
Show All
Source
Cite
Save
Citations (3)
Outcome of Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Standard Risk (SR) Features: Results of CCG-1952, CCG-1991 and POG 9404.
2004
Blood
Yousif Matloub
B.L. Asselin
Linda C. Stork
Meenakshi Devidas
Harland N. Sather
James Nachman
Bruce Camitta
Paul S. Gaynon
Show All
Source
Cite
Save
Citations (3)
1